MRI Study of Blood-brain Barrier Function in CADASIL

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 1, 2021

Primary Completion Date

April 1, 2025

Study Completion Date

April 1, 2026

Conditions
CadasilBlood Brain Barrier Defect
Interventions
OTHER

MRI

All participants underwent an MR examination on a 3T whole-body Prisma MRI system (Siemens, Erlangen, Germany) with a 64-channel head coil, and a 7T whole-body MAGNETOM MR system (Siemens, Erlangen, Germany) using a 32-channel receive/birdcage transmit head coil (NOVA medical). DP-pCASL, Multi-delay pCASL (MD-pCASL) was acquired to evaluate BBB function and cerebral perfusion. T1-weighted magnetization-prepared rapid gradient echo (T1w-MPRAGE) was scanned at both 3T and 7T for registration in the post-processing workflow. T2-weighted fluid-attenuated inversion recovery (T2w-FLAIR) and T2\*-weighted gradient echo (T2\*w-GRE) were acquired at 7T for high-resolution structural images and evaluation of lesions.

Trial Locations (1)

Unknown

RECRUITING

Peking University First Hospital, Beijing

Sponsors
All Listed Sponsors
collaborator

Chinese Academy of Sciences

OTHER_GOV

lead

Peking University First Hospital

OTHER

NCT05902039 - MRI Study of Blood-brain Barrier Function in CADASIL | Biotech Hunter | Biotech Hunter